{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:08:22Z","timestamp":1791011302924,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.jfo.2009.04.017","type":"journal-article","created":{"date-parts":[[2009,6,17]],"date-time":"2009-06-17T04:41:58Z","timestamp":1245213718000},"page":"579.e1-579.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diplopie brutale apr\u00e8s l\u2019\u00e2ge de 50 ans, toujours rechercher une maladie de Horton"],"prefix":"10.1016","volume":"32","author":[{"given":"V.","family":"Da\u00efen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Konat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Villain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2009.04.017_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.1780240706","article-title":"The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications","volume":"24","author":"Bengtsson","year":"1981","journal-title":"Arthritis Rheum"},{"issue":"36","key":"10.1016\/j.jfo.2009.04.017_bib2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/rheumatology\/36.7.823","article-title":"Visual loss and giant cell arteritis","author":"Docken","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jfo.2009.04.017_bib3","doi-asserted-by":"crossref","first-page":"1152e1","DOI":"10.1016\/S0181-5512(05)81156-8","article-title":"La maladie de Horton\u00a0: un classique revisit\u00e9","volume":"28","author":"Labetoulle","year":"2005","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2009.04.017_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","article-title":"Occult giant cell arteritis: Ocular manifestations","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.04.017_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2","article-title":"Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study","volume":"45","author":"Salvarani","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.017_bib6","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.ophtha.2006.05.020","article-title":"Prevalence of a Normal C-Reactive Protein with an Elevated Erythrocyte Sedimentation Rate in Biopsy","volume":"113","author":"Parikh","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2009.04.017_bib7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.017_bib8","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/art.1780330803","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods","volume":"33","author":"Bloch","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.017_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/pgmj.2005.043646","article-title":"Temporal artery biopsy\u2026 who needs one ?","volume":"82","author":"Davies","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jfo.2009.04.017_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","article-title":"Occult giant cell arteritis: ocular manifestations","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.04.017_bib11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0002-9394(14)70136-9","article-title":"Giant cell arteritis: new conceptsin pathogenesis and implications for management","volume":"123","author":"Weyand","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.04.017_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9394(14)70123-0","article-title":"Giant cell arteritis: validity and reliability of various diagnostic criteria","volume":"123","author":"Hayreh","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.04.017_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0002-9394(14)70136-9","article-title":"Giant cell arteritis: new concepts in pathogenesis and implications for management","volume":"123","author":"Weyand","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.04.017_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9394(99)00101-4","article-title":"Efficacy of Unilateral Versus Bilateral Temporal Artery Biopsies for the Diagnosis of Giant Cell Arteritis","volume":"128","author":"Boyev","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.04.017_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","article-title":"Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort","volume":"100","author":"Matteson","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.jfo.2009.04.017_bib16","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment","volume":"41","author":"Gonzales-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.017_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2005.06.011","article-title":"Giant cell (temporal) arteritis: an overview and update","volume":"50","author":"Rahman","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2009.04.017_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2009.04.017_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000070631","article-title":"Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies","volume":"217","author":"Hayreh","year":"2003","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jfo.2009.04.017_bib20","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica","volume":"40","author":"Gabriel","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2009.04.017_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.55.4.218","article-title":"Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?","volume":"55","author":"Van der Veen","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2009.04.017_bib22","first-page":"495","article-title":"A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)","volume":"19","author":"Spiera","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jfo.2009.04.017_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Martinez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2009.04.017_bib24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551209001910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551209001910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:00:39Z","timestamp":1759258839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551209001910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0181551209001910"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2009.04.017","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diplopie brutale apr\u00e8s l\u2019\u00e2ge de 50 ans, toujours rechercher une maladie de Horton","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2009.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}